当前位置:首页 - 行情中心 - 欧康医药(833230) - 财务分析

欧康医药

(833230)

  

流通市值:7.08亿  总市值:15.22亿
流通股本:4670.90万   总股本:1.00亿

欧康医药(833230)财务分析

净利润 + 每股收益
------
  • 净利润(亿元)
  • 每股收益(元)

    截至2025年半年度实现净利润0.03亿元,每股收益0.03元。

股东权益 + 未分配利润
------
  • 股东权益(亿元)
  • 未分配利润(亿元)

    截至2025年半年度最新股东权益40424.38万元,未分配利润9486.78万元。

总资产 + 负债
------
  • 总资产(亿元)
  • 负债(亿元)

    截至2025年半年度最新总资产50254.69万元,负债9830.30万元。

利润表
报告期2025-06-302025-03-312024-12-312024-09-30
营业总收入137,006,339.2558,372,908.24310,268,218.29223,826,491.38
营业总成本134,908,314.4457,115,920.15284,243,069.64201,402,456.95
其他经营收益
营业利润3,506,958.891,874,318.4626,449,325.6223,680,748.45
利润总额3,509,383.81,876,026.6426,290,659.6723,520,014.79
净利润2,867,815.221,550,110.9322,115,851.1819,254,794.76
每股收益
其他综合收益-564.92--40,712.5949,822.77
综合收益总额2,867,250.31,550,110.9322,075,138.5919,304,617.53
资产负债表
报告期2025-06-302025-03-312024-12-312024-09-30
流动资产:
流动资产合计235,377,986.48246,779,364.34258,071,338.63234,863,474.45
非流动资产:
非流动资产合计267,168,865.27273,286,916.09271,140,619.47258,033,224.26
资产总计502,546,851.75520,066,280.43529,211,958.1492,896,698.71
流动负债:
流动负债合计84,220,431.0696,746,477.73108,945,827.4477,884,969.06
非流动负债:
非流动负债合计14,082,601.9914,649,021.8214,915,0755,229,200.38
负债合计98,303,033.05111,395,499.55123,860,902.4483,114,169.44
所有者权益(或股东权益):
归属于母公司股东权益合计403,915,500.93408,238,973.44404,809,662.05409,173,051.3
股东权益合计404,243,818.7408,670,780.88405,351,055.66409,782,529.27
负债和股东权益合计502,546,851.75520,066,280.43529,211,958.1492,896,698.71
现金流量表
报告期2025-06-302025-03-312024-12-312024-09-30
经营活动产生的现金流量:
经营活动现金流入小计174,985,469.6775,712,252.97346,058,224.99247,734,027.69
经营活动现金流出小计152,213,065.2579,297,841.25331,610,009.47260,463,981.02
经营活动产生的现金流量净额22,772,404.42-3,585,588.2814,448,215.52-12,729,953.33
投资活动产生的现金流量:
投资活动现金流入小计70,949,088.6933,727,263.7316,314,013.16266,774,071.59
投资活动现金流出小计79,773,669.5143,724,065.09352,629,498.16279,797,535.41
投资活动产生的现金流量净额-8,824,580.82-9,996,801.39-36,315,485-13,023,463.82
筹资活动产生的现金流量:
筹资活动现金流入小计11,000,000-38,560,80928,560,809
筹资活动现金流出小计18,200,255.17289,730.9945,932,231.0435,735,487.16
筹资活动产生的现金流量净额-7,200,255.17-289,730.99-7,371,422.04-7,174,678.16
汇率变动对现金及现金等价物的影响1,949.4793,141.3528,985.61374,924.95
现金及现金等价物净增加额6,749,517.9-13,778,979.36-28,709,705.91-32,553,170.36
期末现金及现金等价物余额29,560,908.69,032,411.3422,811,390.718,967,926.25
补充资料:
现金及现金等价物的净增加额6,749,517.9--28,709,705.91-
TOP↑